The trial will examine the efficacy, safety, and pharmacodynamics of S-606001 SRT used with ERT in confirmed LOPD adults.

Urinary stone disease is common, associated with substantial morbidity, has a high recurrence rate, and affects quality of life.1,2 Consumption of large volumes of fluids is a foundational strategy ...

This week I want to look at where we are with psychedelics, the mind-altering substances that have somehow made the leap from ...

Boundless Bio's first direct ecDNA-targeting asset, is entering clinical trials with promising preclinical efficacy. Check out why BOLD stock is a buy.

Sen. Rick Scott is turning up the heat on federal health regulators, demanding a broad investigation into how Chinese entities are involved in U.S. clinical trials. The Florida Republican argues that ...

Shenouda With me on today's call are Relmada Therapeutics, Inc.'s CEO, Dr. Sergio Traversa, who will briefly provide a summary of recent business highlights; Dr. Raj S. Pruthi, Relmada Therapeutics, ...

The current quarter emphasized completion of pivotal and ASPIRE trial dosing in Q2 2026, FDA alignment on pooling of clinical and commercial data for BLA submission, and cash runway into 2028, whereas ...

A non-ablative treatment for benign prostatic hyperplasia (BPH)/lower urinary tract symptoms (LUTS) achieved durable ...

One morning in May 2019, a cardiac surgeon stepped into the operating room at Boston Children’s Hospital more prepared than ever before to perform a high-risk procedure to rebuild a child’s heart. The ...

The recent FDA approval of teclistamab (Tecvayli) and daratumumab and hyaluronidase-fihj (Darzelex Faspro) marks a major ...

David Reese believes that AI’s greatest impact will come from improving the thousands of human-led decisions. If Reese, the ...

Exploring the potential of saffron as a therapeutic agent in depression treatment: a comparative review. Yale J Biol Me ...